Related Experiment Video
Updated: Dec 31, 2025
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Cardiac Transplantation: Update on a Road Less Traveled
Tripti Gupta1, Selim R Krim1,2,3
1Department of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA.
Insights
Cardiac transplantation is the definitive treatment for end-stage heart failure. While survival rates have improved, optimizing waitlisting and managing post-transplant complications remain key challenges for heart transplant recipients.
Area of Science:
- Cardiology
- Transplant Surgery
Background:
- Heart failure prevalence is increasing due to an aging population.
- Guideline-directed medical therapy and mechanical support improve outcomes but are not definitive.
- Cardiac transplantation is the definitive treatment for end-stage heart failure.
Purpose of the Study:
- To provide an update on cardiac transplantation.
- To review indications, contraindications, and peri/postoperative management.
- To highlight current challenges in the field.
Main Methods:
- Review of current literature on cardiac transplantation.
- Analysis of indications and contraindications for heart transplant.
- Examination of perioperative and postoperative management strategies.
Main Results:
- Surgical techniques and immunosuppression advances have improved survival rates.
- Graft rejection and chronic immunosuppression side effects impact long-term outcomes.
- Opportunities exist to optimize waitlisting and post-transplant care.
Conclusions:
- Cardiac transplantation remains a critical intervention for end-stage heart failure.
- Ongoing research is needed to address rejection and immunosuppression challenges.
- Further optimization of the transplant process can improve patient outcomes.
Abstract:
Background: With an aging population, the prevalence of heart failure continues to rise. The use of guideline-directed medical therapy and mechanical circulatory support devices has helped to improve outcomes, but cardiac transplantation remains the definitive treatment for end-stage heart failure. Methods: We provide an update on cardiac transplantation and review indications, contraindications, and important aspects of perioperative and postoperative management. We also highlight the current challenges faced by the transplant community. Results: Advances in surgical techniques and immunosuppression have increased survival rates posttransplant. However, the risk of rejection and adverse effects from chronic immunosuppression continue to affect long-term outcomes. Conclusion: Despite tremendous progress in the management of cardiac transplant patients, we have much opportunity to further optimize cardiac transplant waitlisting and improve posttransplant outcomes.
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:29Cardiomyopathy V: Interprofessional Care
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...